For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria. It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.
Scope of the Report:
This report focuses on the Cetirizine Hydrochloride in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global average price of Cetirizine Hydrochloride is in the decreasing trend, from 52.7 USD/K Units in 2012 to 47.7 USD/K Units in 2017. With the situation of global economy and increasing generic medicine, prices will be in decreasing trend in the following five years.
The classification of Cetirizine Hydrochloride includes tablet, capsule and solution, and tablet type of Cetirizine Hydrochloride is the largest segment in the market, its proportion in 2016 is about 45%. Cetirizine Hydrochloride is widely consumed in hospitals, clinics and drug store. The most large application proportion of Cetirizine Hydrochloride is drug store.
Europe is the largest supplier of Cetirizine Hydrochloride, with a production market share over 50% in 2016. USA is the second largest supplier of Cetirizine Hydrochloride products, enjoying production market share nearly 28% in 2016.
The worldwide market for Cetirizine Hydrochloride is expected to grow at a CAGR of roughly 3.0% over the next five years, will reach 1310 million US$ in 2023, from 1100 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- UCB Pharma
- J & J
- HUAPONT Pharm
- Hunan Jiudian Pharm
- Sun Pharma
- Lunan Pharma
- Jubilant Life Sciences
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Drug Store
There are 15 Chapters to deeply display the global Cetirizine Hydrochloride market.
Chapter 1, to describe Cetirizine Hydrochloride Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cetirizine Hydrochloride, with sales, revenue, and price of Cetirizine Hydrochloride, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cetirizine Hydrochloride, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cetirizine Hydrochloride market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cetirizine Hydrochloride sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source